91 related articles for article (PubMed ID: 19326986)
1. Effect of trans sodium crocetinate on brain tumor oxygenation. Laboratory investigation.
Sheehan J; Sherman J; Cifarelli C; Jagannathan J; Dassoulas K; Olson C; Rainey J; Han S
J Neurosurg; 2009 Aug; 111(2):226-9. PubMed ID: 19326986
[TBL] [Abstract][Full Text] [Related]
2. Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide.
Sheehan J; Cifarelli CP; Dassoulas K; Olson C; Rainey J; Han S
J Neurosurg; 2010 Aug; 113(2):234-9. PubMed ID: 20001586
[TBL] [Abstract][Full Text] [Related]
3. Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation: laboratory investigation.
Sheehan J; Ionescu A; Pouratian N; Hamilton DK; Schlesinger D; Oskouian RJ; Sansur C
J Neurosurg; 2008 May; 108(5):972-8. PubMed ID: 18447715
[TBL] [Abstract][Full Text] [Related]
4. Trans sodium crocetinate: functional neuroimaging studies in a hypoxic brain tumor.
Sheehan JP; Popp B; Monteith S; Toulmin S; Tomlinson J; Martin J; Cifarelli CP; Lee DH; Park DM
J Neurosurg; 2011 Oct; 115(4):749-53. PubMed ID: 21682571
[TBL] [Abstract][Full Text] [Related]
5. Protection against focal ischemic injury to the brain by trans-sodium crocetinate. Laboratory investigation.
Manabe H; Okonkwo DO; Gainer JL; Clarke RH; Lee KS
J Neurosurg; 2010 Oct; 113(4):802-9. PubMed ID: 19961314
[TBL] [Abstract][Full Text] [Related]
6. Trans-sodium crocetinate increases oxygen delivery to brain parenchyma in rats on oxygen supplementation.
Okonkwo DO; Wagner J; Melon DE; Alden T; Stone JR; Helm GA; Jane JA
Neurosci Lett; 2003 Dec; 352(2):97-100. PubMed ID: 14625032
[TBL] [Abstract][Full Text] [Related]
7. Increased oxygenation of intracranial tumors by efaproxyn (efaproxiral), an allosteric hemoglobin modifier: In vivo EPR oximetry study.
Hou H; Khan N; O'Hara JA; Grinberg OY; Dunn JF; Abajian MA; Wilmot CM; Demidenko E; Lu S; Steffen RP; Swartz HM
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1503-9. PubMed ID: 15817356
[TBL] [Abstract][Full Text] [Related]
8. Trans-sodium crocetinate improves outcomes in rodent models of occlusive and hemorrhagic stroke.
Wang Y; Yoshimura R; Manabe H; Schretter C; Clarke R; Cai Y; Fitzgerald M; Lee KS
Brain Res; 2014 Oct; 1583():245-54. PubMed ID: 25128603
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator.
Lapchak PA
Brain Res; 2010 Jan; 1309():136-45. PubMed ID: 19891959
[TBL] [Abstract][Full Text] [Related]
10. The Anti-hypoxia Potentials of Trans-sodium Crocetinate in Hypoxiarelated Diseases: A Review.
Klunko NS; Achmad H; Abdullah TM; Mohammed S; Saha I; Salim KS; Obaid RF; Romero-Parra RM; Al-Hasnawi SS; Al-Janabi WH; Farhood B
Curr Radiopharm; 2024; 17(1):30-37. PubMed ID: 37877507
[TBL] [Abstract][Full Text] [Related]
11. Trans-sodium crocetinate does not affect oxygen uptake in rats during treadmill running.
Kemi OJ; Ellingsen O
Scand J Clin Lab Invest; 2005; 65(7):577-84. PubMed ID: 16271989
[TBL] [Abstract][Full Text] [Related]
12. Concurrent treatment with BCNU and Gamma Knife radiosurgery in the rat malignant glioma model.
Cho KT; Kim DG; Paek SH; Chung HT; Jung HW; Park HW
J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):132-41. PubMed ID: 22628080
[TBL] [Abstract][Full Text] [Related]
13. Trans-sodium crocetinate and hemorrhagic shock.
Stennett AK; Murray RJ; Roy JW; Gainer JL
Shock; 2007 Sep; 28(3):339-44. PubMed ID: 17545940
[TBL] [Abstract][Full Text] [Related]
14. Perihematomal Cellular Injury Is Reduced by Trans-sodium Crocetinate in a Model of Intracerebral Hemorrhage.
Wang Y; Schretter C; Clarke R; Lee KS
Mol Neurobiol; 2015 Oct; 52(2):985-9. PubMed ID: 26050085
[TBL] [Abstract][Full Text] [Related]
15. Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI and EPR oximetry study.
Dunn JF; O'Hara JA; Zaim-Wadghiri Y; Lei H; Meyerand ME; Grinberg OY; Hou H; Hoopes PJ; Demidenko E; Swartz HM
J Magn Reson Imaging; 2002 Nov; 16(5):511-21. PubMed ID: 12412027
[TBL] [Abstract][Full Text] [Related]
16. Trans-sodium crocetinate for treating hypoxia/ischemia.
Gainer JL
Expert Opin Investig Drugs; 2008 Jun; 17(6):917-24. PubMed ID: 18491992
[TBL] [Abstract][Full Text] [Related]
17. Imaging experimental brain tumors with 1-aminocyclopentane carboxylic acid and alpha-aminoisobutyric acid: comparison to fluorodeoxyglucose and diethylenetriaminepentaacetic acid in morphologically defined tumor regions.
Uehara H; Miyagawa T; Tjuvajev J; Joshi R; Beattie B; Oku T; Finn R; Blasberg R
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1239-53. PubMed ID: 9390656
[TBL] [Abstract][Full Text] [Related]
18. [Hydrogen sulfide stimulates the development of rat glioblastoma].
Li ZY; Liu SC; Xu PJ; Yang Z; Zhang T
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):254-8. PubMed ID: 22781035
[TBL] [Abstract][Full Text] [Related]
19. Insulin increases the sensitivity of tumors to irradiation: involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption.
Jordan BF; Grégoire V; Demeure RJ; Sonveaux P; Feron O; O'Hara J; Vanhulle VP; Delzenne N; Gallez B
Cancer Res; 2002 Jun; 62(12):3555-61. PubMed ID: 12068004
[TBL] [Abstract][Full Text] [Related]
20. High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging.
Ziegler A; von Kienlin M; Décorps M; Rémy C
Cancer Res; 2001 Jul; 61(14):5595-600. PubMed ID: 11454713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
